Free Trial

WEX (NYSE:WEX) Issues FY 2025 Earnings Guidance

WEX logo with Business Services background

WEX (NYSE:WEX - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 15.370-15.770 for the period, compared to the consensus EPS estimate of 15.035. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.6 billion. WEX also updated its Q3 2025 guidance to 4.300-4.500 EPS.

WEX Stock Up 0.8%

Shares of WEX traded up $1.43 during trading on Friday, reaching $175.53. The company's stock had a trading volume of 745,194 shares, compared to its average volume of 736,756. The company has a fifty day moving average of $144.58 and a two-hundred day moving average of $149.10. WEX has a twelve month low of $110.45 and a twelve month high of $217.47. The company has a market cap of $6.01 billion, a price-to-earnings ratio of 22.19, a P/E/G ratio of 2.52 and a beta of 1.23. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 5.06.

WEX (NYSE:WEX - Get Free Report) last announced its earnings results on Wednesday, April 30th. The business services provider reported $3.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.40 by $0.11. WEX had a return on equity of 39.13% and a net margin of 11.79%. The company had revenue of $636.60 million for the quarter, compared to analyst estimates of $631.42 million. During the same period in the prior year, the company posted $3.46 EPS. WEX's quarterly revenue was down 2.5% on a year-over-year basis. On average, sell-side analysts predict that WEX will post 14.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on WEX. Morgan Stanley upped their price target on WEX from $142.00 to $170.00 and gave the company an "equal weight" rating in a research report on Friday. William Blair reissued a "market perform" rating on shares of WEX in a research report on Friday. Jefferies Financial Group upped their price target on WEX from $130.00 to $135.00 and gave the company a "hold" rating in a research report on Tuesday, May 27th. Robert W. Baird upped their price target on WEX from $186.00 to $198.00 and gave the company an "outperform" rating in a research report on Thursday. Finally, UBS Group increased their target price on WEX from $138.00 to $185.00 and gave the stock a "neutral" rating in a research report on Friday. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, WEX has an average rating of "Hold" and an average target price of $179.00.

Get Our Latest Analysis on WEX

Insiders Place Their Bets

In other WEX news, CEO Melissa D. Smith purchased 3,721 shares of the stock in a transaction dated Thursday, May 29th. The shares were bought at an average cost of $134.57 per share, with a total value of $500,734.97. Following the completion of the acquisition, the chief executive officer owned 101,182 shares of the company's stock, valued at approximately $13,616,061.74. This trade represents a 3.82% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Jennifer Kimball sold 1,400 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $131.08, for a total value of $183,512.00. Following the transaction, the chief accounting officer directly owned 3,177 shares of the company's stock, valued at $416,441.16. This represents a 30.59% decrease in their position. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in WEX stock. Goldman Sachs Group Inc. boosted its position in shares of WEX Inc. (NYSE:WEX - Free Report) by 158.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 350,892 shares of the business services provider's stock after buying an additional 215,036 shares during the quarter. Goldman Sachs Group Inc. owned 1.02% of WEX worth $55,097,000 at the end of the most recent quarter. Institutional investors own 97.47% of the company's stock.

WEX Company Profile

(Get Free Report)

WEX Inc operates a commerce platform in the United States and internationally. The Mobility segment offers fleet vehicle payment solutions, transaction processing, and information management services; and provides account activation and account retention services; authorization and billing inquiries, and account maintenance services; account management; credit and collections services; merchant services; analytics solutions; and ancillary services and offerings.

Featured Stories

Earnings History and Estimates for WEX (NYSE:WEX)

Should You Invest $1,000 in WEX Right Now?

Before you consider WEX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WEX wasn't on the list.

While WEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines